Na_Vchannel variants in patients with painful and nonpainful peripheral neuropathy

Abstract

These results suggest that identification of a genetically defined subpopulation for testing of Na_V1.7 inhibitors in patients with peripheral neuropathy is unlikely and that additional factors, beyond expression of previously reported disease "mutations," are more important for the development of painful neuropathy than previously discussed.